Peter Hecht
Net worth: 3 M $ as of 31/05/2026
Net worth: 3 M $ as of 31/05/2026
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc., founded in 1998, where he served as Chief Executive Officer & Director from 1998 to 2019.
Dr. Hecht is the founder of Cyclerion Therapeutics, Inc., founded in 2019, where he serves as Director since 2023.
Dr. Hecht is currently Chief Executive Officer & Director at Tisento Therapeutics, Inc. since 2023.
Dr. Hecht is currently Director at Kallyope, Inc. since 2020.
Dr. Hecht is currently Director at Mythic Therapeutics, Inc. Dr. Hecht was Director at Microbia, Inc. Dr. Hecht was Director at Whitehead Institute for Biomedical Research.
Dr. Hecht completed undergraduate and graduate degrees at Stanford University.
Dr. Hecht earned a doctorate from the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 5,59,203 ( 12.91% ) | 2 M $ | 31/05/2026 | |
| 30/03/2026 | 3,51,037 ( 100% ) | 1 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director/Board Member | 01/04/2019 |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Director/Board Member | 20/02/2020 |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Director/Board Member | - |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Chief Executive Officer | 01/07/2023 |
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Founder | 01/04/2019 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Director/Board Member | - |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions